# Attune Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/attune-medical

- Industry: Medical Devices & Equipment
- Headquarters: Chicago, US
- Website: www.attune-medical.com
- Total disclosed funding: $17M
- Latest round: Series C (Sep 4, 2018)
- Investors on record: 4

## About

Attune Medical, based in Illinois, US, focuses on developing medical technologies designed to enhance patient safety during cardiac procedures, particularly through advanced esophageal protection systems.Attune Medical specializes in innovative medical solutions, particularly for cardiac procedures. Founded in 2009 in Chicago, US, by Erik Kulstad and Rick McCaulley, the company has undergone strategic shifts to enhance its market presence. On March 5, 2024, Haemonetics Corporation acquired Attune Medical for USD 160.00 mn, reinforcing its offerings in the electrophysiology market. The company has participated in a total of 6 funding deals.Attune Medical's flagship product, the ensoETM® system, provides proactive esophageal protection during radiofrequency cardiac ablation procedures by circulating chilled water through a closed-loop system. This technology is designed to reduce the risk of esophageal injuries, a common complication in these procedures. The ensoETM® system works in conjunction with devices like the Gaymar Medi-Therm® III and Gentherm Blanketrol® II/III, enhancing clinical utility. Their primary customers include hospitals and surgical centers across North America and Europe, aiming to improve patient outcomes by minimizing procedure times and complications.Attune Medical generates revenue through the direct sales of its medical devices, particularly the ensoETM® system, to healthcare facilities. These products are sold in boxes containing multiple units, establishing a structured transaction model within the healthcare sector. The revenue model is supported by partnerships with medical institutions, which focus on providing comprehensive training and support for optimal use of their devices in clinical practice.Following its acquisition by Haemonetics Corporation in April 2024 for USD 160.00 mn, Attune Medical aims to leverage this partnership to enhance its market reach. The acquisition will facilitate the introduction of new products designed for the electrophysiology market. Haemonetics plans to utilize the funding from the acquisition to support research and development initiatives, with potential expansions into new geographic regions and markets anticipated within the following year.

## Funding rounds

- Series C, Sep 4, 2018, $16M — Heartland Angels, Gopher Angels, TWB Investment Partnership, PFG Group
- Series A, Aug 22, 2014, $1.5M — Heartland Angels, Gopher Angels, TWB Investment Partnership

## Investors

- Heartland Angels — Series A, Series C
- Gopher Angels (https://capitalatlas.ai/funds/gopher-angels) — Series A, Series C
- TWB Investment Partnership — Series A, Series C
- PFG Group (https://capitalatlas.ai/funds/pfg-group) — Series C